Johnson & Johnson's yield on cost for the quarter that ended in Dec. 2023 was 4.24.
The historical rank and industry rank for Johnson & Johnson's 5-Year Yield-on-Cost % or its related term are showing as below:
JNJ'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.98 Med: 3.5 Max: 4.28
Current: 4.24
During the past 13 years, Johnson & Johnson's highest Yield on Cost was 4.28. The lowest was 2.98. And the median was 3.50.
JNJ's 5-Year Yield-on-Cost % is ranked better than 72.34% of 499
companies
in the Drug Manufacturers industry
Industry Median: 2.23
vs JNJ: 4.24
Competitive Comparison
For the Drug Manufacturers - General subindustry, Johnson & Johnson's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson & Johnson 5-Year Yield-on-Cost % Distribution
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's 5-Year Yield-on-Cost % falls into.
Johnson & Johnson 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Johnson & Johnson is calculated as
Johnson & Johnson (NYSE:JNJ) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Johnson & Johnson 5-Year Yield-on-Cost % Related Terms
Thank you for viewing the detailed overview of Johnson & Johnson's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Johnson & Johnson (Johnson & Johnson) Business Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JNJ has been successfully added to your